Latest News
- Much shorter radiation treatment found to be safe, effective for people with soft tissue sarcoma
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center found that treating soft tissue sarcoma with radiation over a significantly shorter period of time is safe, and likely just as effective, as a much longer conventional course of treatment.
February 13, 2020 8:00 AM
detail - Unprecedented exploration generates most comprehensive map of cancer genomes charted to date
An international team has completed the most comprehensive study of whole cancer genomes to date, significantly improving our fundamental understanding of cancer and signposting new directions for its diagnosis and treatment.
February 07, 2020 8:00 AM
detail - Cold plasma patch could make immunotherapy more effective for treating melanoma, study finds
An interdisciplinary team of researchers at the UCLA Jonsson Comprehensive Cancer Center has developed a medicated patch that can deliver immune checkpoint inhibitors and cold plasma directly to tumors to help boost the immune response and kill cancer cells.
February 06, 2020 8:00 AM
detail - Botanical drug is shown to help patients with head and neck cancers
In a UCLA-led phase I clinical trial, a new plant-based drug called APG-157 showed signs of helping patients fight oral and oropharyngeal cancers.
February 05, 2020 8:00 AM
detail - Kidney Cancer Program receives $100,000 gift for research on genetic forms of kidney cancer
UCLA Health’s Kidney Cancer Program received $102,483 from Driven to Cure, a nonprofit organization dedicated to advocacy and providing funding for research on rare genetic forms of kidney cancer.
February 04, 2020 6:00 AM
detail - Researchers identify possible new combination treatment for advanced melanoma
A study by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusion of anti-tumor immune cells, or T cells, may produce a stronger immune response that could help fight advanced melanoma.
January 31, 2020 9:00 AM
detail - $18 million gift will expand whole-person care for patients and families facing cancer
An $18 million commitment from the Simms/Mann Family Foundation, led by Dr. Victoria Mann Simms and Ronald Simms, will support UCLA’s expansion of integrative psychosocial care for people with cancer and their families into communities throughout Southern California.
January 30, 2020 8:00 AM
detail - Nine years free of cervical cancer
In 2011, Grace Geaga was diagnosed with cervical cancer. In this video, learn how she credits UCLA Health’s Dr. Sanaz Memarzadeh with saving her life
January 29, 2020 12:00 PM
detail - UCLA researchers find chronic inflammation contributes to cancer metastasis
UCLA researchers have found that chronic exposure to interleukin-1-beta can promote lung cancer metastasis through inheritable changes of gene expression without altering DNA sequence
January 29, 2020 10:30 AM
detail - Scientist awarded $200,000 for pediatric bone sarcoma research
Alice Soragni has received a $200,000 grant from the Alex Lemonade Stand Foundation to support her work on single-cell profiling of pediatric bone sarcomas.
January 24, 2020 8:00 AM
detail - Researchers create framework for evaluating how fast a cancer will grow
An international team of researchers led by UCLA’s Paul Boutros have created a new way to accurately estimate how fast an individual cancer is evolving using open-source software.
January 10, 2020 6:00 AM
detail - Outrunning cancer
Advances in robotic surgery have helped physicians remove throat tumors without any facial incision and patients can go home within a few days.
December 18, 2019 9:00 AM
detail - Targeted therapy drug helps women with aggressive breast cancer live longer
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.
December 11, 2019 2:00 PM
detail - UCLA study shows inhibition of gene helps overcome resistance to immunotherapy
New study from UCLA scientists helps explain why some people with advanced cancer may not respond to one of the leading immunotherapies, PD-1 blockade, and how a new combination approach may help overcome resistance to the immunotherapy drug.
December 09, 2019 8:00 AM
detail - Cancer researcher receives grant to study how deep learning can improve immunotherapy
Willy Hugo, PhD, has received a $75,000 grant from the Margaret E. Early Medical Research Trust to help understand the underlying mechanism of response to immune checkpoint inhibitors, a type of immunotherapy drug.
December 03, 2019 8:00 AM
detail - Researchers identify protein that governs human blood stem cell self-renewal
UCLA scientists have discovered a link between a protein and the ability of human blood stem cells to self-renew.
November 29, 2019 12:00 PM
detail - Automated technique helps identify cancer cell metabolism inhibitors
UCLA Jonsson Comprehensive Cancer Center researchers have developed a new automated method for testing hundreds of molecules at a time to find out which ones block cancer cells from consuming glucose — the sugars they need to spread and grow.
November 29, 2019 8:00 AM
detail - A pep talk for pancreatic cancer
In this video, meet UCLA Jonsson Comprehensive Cancer Center researchers Drs. Randy Hecht, David Dawson, Zev Wainberg and Timothy Donahue, who are working on new ways to treat this tough disease, and offer new hope for the future because of breakthroughs in research and patient care.
November 26, 2019 8:00 AM
detail - Dozens of UCLA scientists rank among world’s most-cited researchers
Three UCLA researchers have received awards totaling more than $18 million from the California Institute for Regenerative Medicine, the state’s stem cell agency.
November 21, 2019 9:00 AM
detail